← Eichor
Condition: Control Subjects Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Control Subjects

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressi
Phase 3 · 60 location(s) · Neurocrine Biosciences · NCT07196501Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin
Phase 3 · 1 location(s) · Fujian Shengdi Pharmaceutical Co., Ltd. · NCT07060456Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.
Phase 1 · 3 location(s) · HC Biopharma Inc. · NCT06657703Microneurography and Intraneural Microstimulation for Upper Limb Sensory Investigation in Healthy and Amputee Subjects
NA · 1 location(s) · Azienda Ospedaliero, Universitaria Pisana · NCT07691957A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.
Phase 1 · 1 location(s) · Shanghai Pharmaceuticals Holding Co., Ltd · NCT06839131Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects
Phase 1 · 1 location(s) · Shenyang Sunshine Pharmaceutical Co., LTD. · NCT07058779Phase 1 Single Ascending Dose Study
Phase 1 · 1 location(s) · Neuramedy Co. Ltd. · NCT06934941The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
Phase 2 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT07507513A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Partici
Phase 3 · 64 location(s) · AbbVie · NCT06810505A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2061
Phase 1 · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07241910Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
Phase 2 · 2 location(s) · Meribank Biotech Co., Ltd. · NCT06491043Phase 1 Study of Intravaginal KB15A
Phase 1 · 1 location(s) · ZabBio Inc. · NCT07222020An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancr
Phase 3 · 2 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT05884255Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ± Toripalimab in HR-/HER2-low Breast Canc
Phase 2 · 1 location(s) · RemeGen Co., Ltd. · NCT06642545A Randomized Controlled Trial on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy in Subjects Wit
Phase 2 · 1 location(s) · Min Long · NCT07183761HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)
Phase 2 · 20 location(s) · Tasly Pharmaceutical Group Co., Ltd · NCT05632861A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
Phase 2 · 9 location(s) · Dasher Neuroscience Inc. · NCT06848231Effectiveness of Two Health Education Interventions in the Prevention of Caries and Gingivitis in Orthodontic Patients
NA · 1 location(s) · Universidad Nacional de Colombia · NCT05979805Phase I Study of MT1011 Injection in Healthy Subjects
Phase 1 · 1 location(s) · Shaanxi Micot Pharmaceutical Technology Co., Ltd. · NCT07024160First-in-human Study of HSK56630 in Healthy Subjects
Phase 1 · 1 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07580794A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjec
Phase 1 · 1 location(s) · Peking University First Hospital · NCT06669429A Placebo-controlled Trial of Folinic Acid in Children With ASD
Phase 2 · 1 location(s) · Prof. Adi Aran · NCT07642661Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Phase 3 · 32 location(s) · Inmunotek S.L. · NCT04891237A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects
Phase 1 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT07594847Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments
NA · 1 location(s) · Motion Informatics LTD · NCT07404761Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · 205 location(s) · Gilead Sciences · NCT06051617A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's
Phase 1/Phase 2 · 2 location(s) · Sumitomo Pharma America, Inc. · NCT06753331KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Phase 3 · 10 location(s) · Khondrion BV · NCT06451757Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis
Phase 3 · 1 location(s) · Shanghai Mabgeek Biotech.Co.Ltd · NCT06779136Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NA · 1 location(s) · NAOS Les Laboratoires · NCT06756438
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.